Abstract
Liver transplantation is the only therapeutic treatment for patients with end-stage liver diseases. However, donor organ scarcity is the major limitation, and therefore, alternative strategies are urgently needed. The ultimate goal for successful cell-based therapies is the ability of transplanted cells to efficiently engraft and reconstitute injured liver mass. To evaluate the repopulation capacity of transplanted cells, it is essential to identify their specific characteristics, as well as to study the mechanism(s) Through which transplanted donor cells replace tissue mass in hepatic microenvironments, using well-established cell transplantation models. To date, rat fetal liver stem/progenitor cells represent the most efficient cell population to reconstitute the near-normal liver and the liver microenvironment with advanced fibrosis/cirrhosis, and therefore, can be used for developing strategies in engineering potential donor cells in the future that will be useful for clinical application in hepatic cell therapy.
The present protocol describes the isolation of epithelial stem/progenitor cells derived from ED14/15 fetal livers of DPPIV+ F344 or F344-Tg(EGFP) F455/Rrrc rats, the immunohistochemical staining method to detect E-cadherin-positive epithelial cells within unfractionated cell isolates, their transplantation into different DPPIV– liver microenvironments (near-normal, retrorsine-treated, and TAA-induced fibrotic/cirrhotic liver), as well as detection methods to follow the fate of transplanted cells in the recipient liver (see Fig. 1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Oertel M (2011) Fetal liver cell transplantation as a potential alternative to whole liver transplantation? J Gastroenterol 46:953–965
Gramignoli R, Vosough M, Kannisto K, Srinivasan RC, Strom SC (2015) Clinical hepatocyte transplantation: practical limits and possible solutions. Eur Surg Res 54:162–177
Thompson NL, Hixson DC, Callanan H, Panzica M, Flanagan D, Faris RA, Hong WJ, Hartel-Schenk S, Doyle D (1991) A Fischer rat substrain deficient in dipeptidyl peptidase IV activity makes normal steady-state RNA levels and an altered protein. Use as a liver-cell transplantation model. Biochem J 273:497–502
Rajvanshi PA, Kerr A, Bhargava KK, Burk RD, Gupta S (1996) Studies of liver repopulation using the dipeptidyl peptidase IV deficient rat and other rodent recipients: cell size and structure relationships regulate capacity for increased transplanted hepatocytes mass in the liver lobule. Hepatology 23:482–496
Sandhu JS, Petkov PM, Dabeva MD, Shafritz DA (2001) Stem cell properties and repopulation of the rat liver by fetal liver epithelial progenitor cells. Am J Pathol 159:1323–1334
Oertel M, Menthena A, Dabeva MD, Shafritz DA (2006) Cell competition leads to a high level of normal liver reconstitution by transplanted fetal liver stem/progenitor cells. Gastroenterology 130:507–520
Menthena A, Koehler C, Sandhu JS, Yovchev MI, Hurston E, Shafritz DA, Oertel M (2011) Activin A, p15INK4b signaling, and cell competition promote stem/progenitor cell repopulation of livers in aging rats. Gastroenterology 140:1009–1020
Dabeva MD, Petkov PM, Sandhu J, Oren R, Laconi E, Hurston E, Shafritz DA (2000) Proliferation and differentiation of fetal liver epithelial progenitor cells after transplantation into adult rat liver. Am J Pathol 156:2017–2031
Oertel M, Menthena A, Chen Y-Q, Teisner B, Jensen CH, Shafritz DA (2008) Purification of fetal liver stem/progenitor cells containing all the repopulation potential for normal adult rat liver. Gastroenterology 134:823–832
Morata G, Ripoll P (1975) Minutes: mutants of drosophila autonomously affecting cell division rate. Dev Biol 42:211–221
Laconi E, Oren R, Mukhopadhyay DK, Hurston E, Laconi S, Pani P, Dabeva MD, Shafritz DA (1998) Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am J Pathol 153:319–329
Yovchev MI, Xue Y, Shafritz DA, Locker J, Oertel M (2014) Repopulation of the fibrotic/cirrhotic rat liver by transplanted hepatic stem/progenitor cells and mature hepatocytes. Hepatology 59:284–295
Müller A, Machnik F, Zimmermann T, Schubert H (1988) Thioacetamide-induced cirrhosis-like liver lesions in rats--usefulness and reliability of this animal model. Exp Pathol 34:229–236
Higgins GM, Anderson RM (1931) Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 12:186–202
Yovchev MI, Dabeva MD, Oertel M (2013) Isolation, characterization, and transplantation of adult liver progenitor cells. Methods Mol Biol 976:37–51
Acknowledgment
I would like to thank Dr. David A. Shafritz (Dept. of Medicine, Albert Einstein College of Medicine, Bronx, NY), all my colleagues and postdoctoral fellows for their contributions to the studies related to FLSPC transplantation, which were conducted at Einstein and the University of Pittsburgh.
Conflict of interests: The authors indicate no potential conflicts of interest.
Financial support: Supported by NIH grant R01 DK090325 (to M.O.).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Yovchev, M.I., Oertel, M. (2017). Fetal Liver Stem/Progenitor Cell Transplantation: A Model to Study Tissue Mass Replacement and Cell-Based Therapies. In: Stock, P., Christ, B. (eds) Hepatocyte Transplantation. Methods in Molecular Biology, vol 1506. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6506-9_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6506-9_7
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6504-5
Online ISBN: 978-1-4939-6506-9
eBook Packages: Springer Protocols